External Publication
Visit Post

Dr Reddy's Launches Oral Semaglutide Biosimilar Obeda In India

NDTV.com May 20, 2026
Source
Oral semaglutide, a glucagon-Like Peptide-1 receptor agonist (GLP-1 RA), is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes.

Discussion in the ATmosphere

Loading comments...